Peter Lynch once said “never invest in any idea you can’t illustrate with a crayon.” Does that hold true in the highly scientific world of biopharma? Find out in this special edition of Industry Focus: Healthcare with Motley Fool healthcare analysts Kristine Harjes and Max Macaluso.